Relma-cel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Relma-cel, covering 2025-03-14 to 2025-03-14. Get the full timeline:
Most recent: Clinical Trial Update: Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma [Phase 2]